RMA of New York, operating as the Division of Reproductive Endocrinology at Mount Sinai Hospital, is broadly renowned as a global leader in providing the highest-quality, most advanced in vitro fertilization (IVF) technology available. The physician-scientists have focused significant efforts in understanding the causes of infertility and are investigating biomarkers that may help provide personalized genomic indicators for women to predict their reproductive potential. Our team is committed to enabling couples to build families through the marvels discovered by progressive research in reproductive medicine.
Current research studies include screening embryos for disease and implantation potential, understanding the effects of Polycystic Ovarian Syndrome on pregnancy and the health of a newborn with regard to epigenetics and cellular programming, and stem cell biology. The team has recently published research on ectopic pregnancies, same-sex female parenting, and predictors of success in reproductive treatment. Mount Sinai's IVF program is also using time lapse photography to understand early embryonic cell division and embryo viability. Mount Sinai has also taken the lead in fertility preservation for women with cancer (oncofertility) and women who choose to cryopreserve or freeze their eggs to electively delay childbearing.
To learn more about our continued research or to participate in one of our current clinical studies, please visit our research page.